Income Statement
MODULAR MEDICAL, INC.
MODD
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY | Mar 31, 2021 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY | Jun 30, 2017 2017 FY | Jun 30, 2016 2016 FY | Jun 30, 2014 2014 FY | Jun 30, 2013 2013 FY | Jun 30, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 |
|
Operating Expenses
|
19.05 | 17.53 | 13.88 | 14.93 | 7.34 | 5.35 | 2.58 | 0.09 | 0.01 | 0.01 | 0.01 | 0.01 |
|
Research & Development
|
14.70 | 12.88 | 9.06 | 7.73 | 4.08 | 3.03 | 1.88 | - | - | - | - | - |
|
Selling, General & Administrative
|
4.35 | 4.65 | 4.82 | 7.20 | 3.25 | 2.31 | 0.42 | 0.09 | 0.01 | 0.01 | 0.01 | 0.01 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-19.05 | -17.53 | -13.88 | -14.93 | -7.34 | -5.35 | -2.58 | -0.09 | -0.01 | -0.01 | -0.01 | -0.01 |
|
Non-Operating Income
|
-0.23 | -0.06 | 0.00 | 3.70 | 0.04 | -0.03 | -0.04 | 0.02 | 0.02 | - | - | - |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | 2.75 | -0.04 | - | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | - | - | - | -0.02 | - | -0.01 | -0.01 |
|
Income Before Tax
|
-18.82 | -17.47 | -13.88 | -18.63 | -7.38 | -5.32 | -2.54 | -0.11 | -0.03 | - | - | - |
|
Income Tax Expense
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-18.82 | -17.47 | -13.88 | -18.63 | -7.38 | -5.32 | -2.54 | -0.11 | -0.03 | -0.02 | -0.02 | -0.02 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Mar 31, 2025 2024 FY | Mar 31, 2024 2023 FY | Mar 31, 2023 2022 FY | Mar 31, 2022 2021 FY | Mar 31, 2021 2020 FY | Mar 31, 2020 2019 FY | Mar 31, 2019 2018 FY | Jun 30, 2017 2017 FY | Jun 30, 2016 2016 FY | Jun 30, 2014 2014 FY | Jun 30, 2013 2013 FY | Jun 30, 2012 2012 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-17.99 | -17.10 | -13.73 | -14.81 | -7.23 | -5.31 | -2.56 | -0.09 | -0.01 | -0.01 | -0.01 | -0.01 |
|
Earnings Per Share (Basic)
|
-0.51 | -0.78 | -1.28 | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
-0.51 | - | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
37.01 | 22.38 | 10.88 | - | - | - | 16.59 | 1.65 | - | - | - | - |
|
Diluted Weighted Avg Shares
|
37.01 | - | - | - | - | - | 16.59 | 1.65 | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | - |